|
國藥控股股份有限公司 -H股, 01099.HK - 綜合損益表 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
營業額 |
596,569,565 |
552,147,550 |
521,051,235 |
456,414,611 |
425,272,726 |
344,525,821 |
308,353,579 |
258,387,689 |
228,672,929 |
200,131,261 |
166,866,146 |
136,501,660 |
102,224,807 |
69,233,669 |
52,668,164 |
38,191,909 |
31,110,214 |
23,736,642 |
經營溢利 |
20,209,195 |
20,604,466 |
19,711,976 |
17,759,975 |
16,136,744 |
15,396,806 |
13,140,388 |
10,213,720 |
9,227,323 |
7,861,922 |
6,101,920 |
4,868,904 |
3,636,216 |
2,408,815 |
1,891,964 |
1,173,510 |
789,346 |
390,407 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-100,871 |
-50,330 |
-148,367 |
-8,972 |
-45,633 |
聯營公司 |
1,107,349 |
1,067,067 |
1,069,868 |
987,463 |
887,074 |
843,169 |
476,879 |
232,190 |
165,060 |
162,642 |
138,758 |
135,718 |
107,402 |
90,008 |
67,772 |
54,186 |
40,035 |
19,193 |
除稅前經營溢利 |
19,512,137 |
18,563,819 |
17,003,162 |
15,598,096 |
13,759,810 |
12,207,940 |
11,226,799 |
8,924,822 |
7,469,173 |
5,934,603 |
4,620,505 |
4,022,191 |
3,127,600 |
2,397,952 |
1,909,406 |
1,079,329 |
820,409 |
363,967 |
稅項 |
4,502,309 |
4,218,377 |
3,938,389 |
3,500,805 |
3,139,738 |
2,803,456 |
2,561,821 |
2,033,227 |
1,728,264 |
1,383,030 |
1,040,793 |
936,497 |
725,050 |
567,595 |
465,314 |
259,286 |
284,460 |
181,519 |
少數股東權益 |
5,956,068 |
5,819,787 |
5,306,127 |
4,910,013 |
4,367,535 |
3,568,642 |
3,089,394 |
2,244,251 |
1,968,687 |
1,676,750 |
1,329,710 |
1,106,313 |
841,944 |
621,606 |
476,927 |
232,430 |
155,029 |
81,117 |
股東應占溢利 |
9,053,760 |
8,525,655 |
7,758,646 |
7,187,278 |
6,252,537 |
5,835,842 |
5,575,584 |
4,647,344 |
3,772,222 |
2,874,823 |
2,250,002 |
1,979,381 |
1,560,606 |
1,208,751 |
967,165 |
587,613 |
380,920 |
101,331 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
4,430,248 |
4,165,019 |
3,922,058 |
3,597,114 |
3,114,076 |
1,351,328 |
1,204,234 |
1,020,958 |
965,611 |
835,246 |
676,926 |
567,125 |
460,145 |
230,927 |
187,034 |
126,376 |
95,882 |
87,870 |
利息 |
2,976,638 |
3,541,864 |
3,772,384 |
3,428,109 |
3,445,126 |
3,076,538 |
2,808,037 |
1,574,157 |
1,784,132 |
2,212,858 |
1,753,265 |
1,351,648 |
881,509 |
318,934 |
228,331 |
243,839 |
142,021 |
101,539 |
利息撥作發展資本 |
20,051 |
21,538 |
15,549 |
3,353 |
2,619 |
6,511 |
9,841 |
20,141 |
22,744 |
21,638 |
22,638 |
34,058 |
34,637 |
7,125 |
3,067 |
3,202 |
2,998 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
23.07 |
22.72 |
23.16 |
22.44 |
22.82 |
22.96 |
22.82 |
22.78 |
23.14 |
23.3 |
22.53 |
23.28 |
23.18 |
23.67 |
24.37 |
24.07 |
34.67 |
49.87 |
營業額增長(%) |
8.05 |
5.97 |
14.16 |
7.32 |
23.44 |
11.73 |
19.34 |
12.99 |
14.26 |
19.94 |
22.24 |
33.53 |
47.65 |
31.45 |
37.9 |
22.75 |
31.06 |
0.0 |
股東應占溢利增長(%) |
6.19 |
9.89 |
7.95 |
14.95 |
7.14 |
4.67 |
19.97 |
23.2 |
31.22 |
27.77 |
13.67 |
26.83 |
29.11 |
24.98 |
64.59 |
54.26 |
275.92 |
|
核數師意見 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|